Important

InGeneron's Transpose® Ultra System is for investigational use only in the US. By Clicking 'Continue' I confirm acknowledgment

Continue

Management Team

Page Header Image

Fabian Alt, M.Sc.
Chief Financial Officer

Fabian Alt previously served in the Investment Banking Division of Goldman Sachs’s London office. His experience extends across more than 20 completed capital market and M&A transactions, including several equity capital offerings and IPOs. Fabian received his master’s in finance from the London School of Economics and Political Science, earned an honors master’s in technology management from the Technical University of Munich and Ludwig-Maximilians-University Munich, and received a master’s in physics from the Technical University of Munich. In addition, he completed research stays at the Max Planck Institute for Quantum Optics and Massachusetts Institute of Technology.

 

David Mercer
Director of Engineering and Product Operations

David Mercer has more than 12 years of product development experience in medical devices. Previously, he worked at Acelity as Lead Product Development Engineer developing new negative pressure therapy devices within the Prevena and Abthera surgical product lines. Before Acelity David developed mechanical and electromechanical drug delivery systems at DCA Design International in the UK. David received his degree in mechanical engineering specializing in product design from The University of Glasgow.

 

Christopher Alt, MD
Director of Medical and Scientific Affairs

Christopher Alt has 15 years of research experience in medicine and has a proven track record of clinical trial management. Previously, he worked at MD Anderson Cancer Center in the department of molecular pathology. Christopher joined InGeneron in 2015 as European director of medical and scientific affairs before taking on the role of global director of medical and scientific affairs in 2020. Christopher received his medical degree from PMU Salzburg in Austria.